ClinicalTrials.Veeva

Menu

Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders

U

Université Catholique de Louvain

Status

Enrolling

Conditions

Children Suffering From Cortical Visual Impairment

Treatments

Diagnostic Test: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Some children present visual difficulties linked not to damage to the eye, but to damage to the brain. This type of dysfunction of the visual cerebral pathways leads, for example, to difficulties in recognition, visuomotor coordination or visuo-spatial disorders. These highly specific disorders are known as "cortical visual impairment" (CVI). Despite their real impact on children's development, these disorders are still poorly diagnosed in the French-speaking world. As a result, follow-up and care for these children are poorly adapted. A better understanding of neurovisual disorders and the availability of validated tools in French are therefore essential. Indeed, it is currently considered that 3 to 4% of children aged four to six, i.e. around one child per kindergarten class, have a CVI following a neuro-logical lesion acquired in the perinatal period.

Because of the lack of a valid tool in French, the aim of the present study is to provide the results of a validation study of a parental questionnaire for screening children with warning signs of CVI in French. This questionnaire will be offered online using the Qualtrics tool. In order to evaluate the relevance of this questionnaire, it will be proposed, on the one hand, to parents whose child (aged 3 to 12) does not present any particular developmental difficulties, and on the other hand, to parents whose child (aged 3 to 12) seems to present signs of neurovisual disorders. By comparing their answers, the investigators hope that certain questions will reveal elements typical of neurovisual disorders/CVI, thus demonstrating the relevance of this questionnaire in facilitating diagnosis.

Enrollment

250 estimated patients

Sex

All

Ages

3+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Parents of a child aged between 3 and 12
  • Their mother tongue must be French, to ensure that they understand the questions asked in writing.

Control group:

  • Children of the parents surveyed who do not present any medical, school or family developmental particularities.

Clinical group

  • Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment.

Exclusion criteria

  • no specific criteria (see inclusion criteria)

Trial design

250 participants in 1 patient group

questionnaire
Description:
Each parent has to complete a online questionnaire
Treatment:
Diagnostic Test: Questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Anne Bragard, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems